About
Acceptance rate:
26%
Time to first decision with review (median):
44 days*
Acceptance to publication:
17 days*
Impact Factor (JCR):
4.463
Citescore:
7
Citescore rank:
22/193
Aims and scope
Journal of Clinical Pathology (JCP) offers a mix of cutting-edge academic research and practical clinical advice. As one of the few broad scope pathology journals, it enables the busy pathologist to keep up to date with the latest developments in all disciplines of pathology.
In addition to original research, JCP publishes a wide range of other content types aimed at the trainee or practising pathologist, including review articles on hot topics, best practice articles for clinical investigations, in depth summaries of key genes and molecules in pathogenesis, and multi-disciplinary grand rounds cases. Selected articles have accredited online learning modules for self-assessment and CME.
JCP is the official journal of the Association of Clinical Pathologists.
Molecular Pathology was merged with JCP in 2003.
For information about the Journal of Clinical Pathology Editor-in-Chief Tahir Pillay and his editorial team, please refer to the Editorial Board page.
Plan S compliance
Journal of Clinical Pathology is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Journal information
Ownership
JCP is owned by the Association of Clinical Pathologists and BMJ
Publication Model
Subscription; with hybrid open access option
Frequency
Monthly
Launch date
1947; Molecular Pathology merged with JCP in 2003
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Expanded; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
0021-9746
Online ISSN
1472-4146
Journal Statistics (2021)
Acceptance rate: 26%
Speed
Time to first decision without review: 20 days (median)
Time to first decision with review: 44 days (median)
Time from acceptance to publication: 17 days (median)
Impact
Impact Factor category: Pathology
Impact Factor (JCR): 4.463
Impact Factor rank: 22/77
5 Year Impact Factor: 3.516
Journal Citation Indicator (JCI): 1.17
Eigenfactor Score: 0.00615
Citescore: 7
Citescore rank: 22/193
SciMago Journal Rank (SJR): 1.106
Reach
2021 total content views: 1,415,288
2021 total Altmetric mentions: 769
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact information
For all contact information please refer to the contact us page.
For authors
Please refer to the Instructions for authors
Subscriptions
To advertise
Rights and permissions
Affiliations
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.